New drug combo aims to shrink liver tumors before surgery
NCT ID NCT07515469
First seen Apr 08, 2026 · Last updated Apr 21, 2026 · Updated 2 times
Summary
This study is testing whether giving a combination of two immunotherapy drugs before surgery can help people with early-stage liver cancer that is at high risk of coming back. The goal is to see if this pre-surgery treatment can shrink tumors and lower the chance of the cancer returning after the operation. Researchers will enroll about 30 patients to check the safety of this approach and measure how many patients remain cancer-free one year after surgery.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HCC - HEPATOCELLULAR CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.